Arax Advisory Partners’s Core Laboratories CLB Stock Holding History

Arax Advisory Partners’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.78K	Sell	106 -48	-31%	-$859	﹤0.01%	3136
2025 Q4	$2.47K	Sell	154 -578	-79%	-$8.6K	﹤0.01%	3187
2025 Q3	$9.05K	Buy	+732	New	+$8.58K	﹤0.01%	2642
2025 Q1	–	Sell	-165	Closed	-$2.86K	–	2733
2024 Q4	$2.86K	Hold	165	–	–	﹤0.01%	1921
2024 Q3	$3.06K	Buy	+165	New	+$3.31K	﹤0.01%	1911
2018 Q4	$43K	Sell	728 -27	-4%	-$2.33K	0.02%	287
2018 Q3	$87K	Buy	755 +28	+4%	+$3.16K	0.04%	218
2018 Q2	$91K	Buy	727 +368	+103%	+$44.8K	0.04%	168
2018 Q1	$38K	Sell	359 -95	-21%	-$10.5K	0.02%	226
2017 Q4	$49K	Sell	454 -2	-0.4%	-$200	0.02%	214
2017 Q3	$45K	Hold	456	–	–	0.02%	223
2017 Q2	$46K	Buy	456 +17	+4%	+$1.83K	0.02%	237
2017 Q1	$50K	Buy	439 +63	+17%	+$7.32K	0.02%	206
2016 Q4	$45K	Buy	+376	New	+$41.6K	0.02%	180

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arax Advisory Partners's CLB Position: Q1 2026 in Review

Arax Advisory Partners reduced its Core Laboratories (CLB) stake by 31% in Q1 2026, selling an estimated $859 and leaving 106 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

Arax Advisory Partners first reported a position in CLB in Q4 2016 and has held it in 14 quarters since. The position peaked at $91K in Q2 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

Arax Advisory Partners held 106 shares of Core Laboratories worth $1.78K as of Q1 2026.
Arax Advisory Partners sold 48 Core Laboratories shares in Q1 2026, an estimated $859.
Core Laboratories made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3136 holding.
Arax Advisory Partners first reported a position in Core Laboratories in Q4 2016 and has held it in 14 quarters since.
Arax Advisory Partners's Core Laboratories position peaked at $91K in Q2 2018.
190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.